Merck price target raised to $175 from $145 at UBS
Upside potential for MRK with higher target
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Upside potential for MRK with higher target
What happened, with direct paths to the underlying reporting
UBS raises MRK target to $175; current price reported at $152.22.
Target: $175
Posted price: $152.22
Analyst firm: UBS
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.